Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Helenalin: An Anti-Inflammatory and Anti-Neoplastic Agent: A Review

Author(s): Priyanka Kriplani*, Kumar Guarve and Uttam S. Baghel

Volume 16, Issue 8, 2020

Page: [1134 - 1146] Pages: 13

DOI: 10.2174/1573407216666191226121004

Price: $65

Abstract

Objective: Helenalin is a natural anti-inflammatory agent that is proving its efficacy to treat various medical conditions. Though many plants are proving their effectiveness but their mechanisms are still not well understood. The objective of the review is to summarize various mechanisms of helenalin to treat inflammatory disorders and cancers, adverse effects, and avenues of further research.

Methods: Structured research was carried out including Pub med, Science direct Medline, Research Gate and Google Scholar to find all articles published on helenalin. Various keywords used were “helenalin”, “Arnica”, “cancer”, “anti-inflammatory”, “cardiovascular”, “IBD”, “pharmacokinetics” etc. The aim of the review was to find out the problem prevailing in the data published to date which will help the researchers to investigate the molecule clinically.

Results: Seventy articles are included in the review. Helenalin is found to cure chronic conditions like rheumatoid arthritis, ulcers and malignancies like stomach, colon, breast, larynx, lung and skin cancers via multiple mechanisms. These diseases do not proceed via a unilateral pathway. So, it can be a useful molecule to treat numerous diseases.

Conclusion: This review article will help us to systemically analyze the wealth of information concerning the medicinal properties of helenalin and to recognize the gaps which have vetoed its pervasive application in the medical community.

Keywords: Helenalin, Arnica montana, anti-inflammatory, sesquiterpene lactone cancer, cardioprotective, unilateral pathway, pharmacokinetics.

Graphical Abstract

[1]
Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as “Curecumin”: From kitchen to clinic. Biochem. Pharmacol., 2008, 75(4), 787-809.
[http://dx.doi.org/10.1016/j.bcp.2007.08.016] [PMID: 17900536]
[2]
Fadus, M.C.; Lau, C.; Bikhchandani, J.; Lynch, H.T. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. J. Tradit. Complement. Med., 2016, 7(3), 339-346.
[http://dx.doi.org/10.1016/j.jtcme.2016.08.002] [PMID: 28725630]
[3]
Dhiman, A.; Nanda, A.; Ahmad, S. Novel Herbal Drug Delivery System (NHDDS): The need of hour. International Conference on Environment. Chem. Biol., 2012, 49, 171-175.
[4]
Lin, X.; Zhang, S.; Huang, R.; Wei, L.; Tan, S.; Liang, S.; Tian, Y.; Wu, X.; Lu, Z.; Huang, Q. Helenalin attenuates alcohol-induced hepatic fibrosis by enhancing ethanol metabolism, inhibiting oxidative stress and suppressing HSC activation. Fitoterapia, 2014, 95, 203-213.
[http://dx.doi.org/10.1016/j.fitote.2014.03.020] [PMID: 24704336]
[5]
Auld, C.A.; Hopkins, R.G.; Fernandes, K.M.; Morrison, R.F. Novel effect of helenalin on Akt signaling and Skp2 expression in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun., 2006, 346(1), 314-320.
[http://dx.doi.org/10.1016/j.bbrc.2006.05.117] [PMID: 16750815]
[6]
Drogosz, J.; Janecka, A. Helenalin - A sesquiterpene lactone with multidirectional activity. Curr. Drug Targets, 2019, 20(4), 444-452.
[PMID: 30317996]
[7]
Dirsch, V.M.; Stuppner, H.; Vollmar, A.M. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. Cancer Res., 2001, 61(15), 5817-5823.
[PMID: 11479221]
[8]
Berges, C.; Fuchs, D.; Opelz, G.; Daniel, V.; Naujokat, C. Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms. Mol. Immunol., 2009, 46(15), 2892-2901.
[http://dx.doi.org/10.1016/j.molimm.2009.07.004] [PMID: 19656571]
[9]
Lyss, G.; Knorre, A.; Schmidt, T.J.; Pahl, H.L.; Merfort, I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J. Biol. Chem., 1998, 273(50), 33508-33516.
[http://dx.doi.org/10.1074/jbc.273.50.33508] [PMID: 9837931]
[10]
Fernandes, K.M.; Auld, C.A.; Hopkins, R.G.; Morrison, R.F. Helenalin-mediated post-transcriptional regulation of p21(Cip1) inhibits 3T3-L1 preadipocyte proliferation. J. Cell. Biochem., 2008, 105(3), 913-921.
[http://dx.doi.org/10.1002/jcb.21894] [PMID: 18729080]
[11]
Thomas, R.; Davies, M.N.; O’Sulliva, J. Compositions and methods for modulating immune responses. U.S. Patent 20150202285A1, 2006.
[12]
Davis, R.L.; Sanchez, A.C.; Lindley, D.J.; Williams, S.C.; Syapin, P.J. Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression. Nitric Oxide, 2005, 12(4), 200-209.
[http://dx.doi.org/10.1016/j.niox.2005.04.005] [PMID: 15890551]
[13]
Gorbacheva, L.; Strukova, S.; Pinelis, V.; Ishiwata, S.; Stricker, R.; Reiser, G. NF-κB-dependent and -Independent pathways in the protective effects of activated protein C in hippocampal and cortical neurons at excitotoxicity. Neurochem. Int., 2013, 63(2), 101-111.
[http://dx.doi.org/10.1016/j.neuint.2013.05.008] [PMID: 23727063]
[14]
Schomburg, C.; Schuehly, W.; Da Costa, F.B.; Klempnauer, K.H.; Schmidt, T.J. Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: Structure-activity relationships. Eur. J. Med. Chem., 2013, 63, 313-320.
[http://dx.doi.org/10.1016/j.ejmech.2013.02.018] [PMID: 23501116]
[15]
Huang, P.R.; Yeh, Y.M.; Wang, T.C. Potent inhibition of human telomerase by helenalin. Cancer Lett., 2005, 227(2), 169-174.
[http://dx.doi.org/10.1016/j.canlet.2004.11.045] [PMID: 16112419]
[16]
Adams, M.; Berset, C.; Kessler, M.; Hamburger, M. Medicinal herbs for the treatment of rheumatic disorders-A survey of European herbals from the 16th and 17th century. J. Ethnopharmacol., 2009, 121(3), 343-359.
[http://dx.doi.org/10.1016/j.jep.2008.11.010] [PMID: 19063957]
[17]
Jang, J.H.; Iqbal, T.; Min, K.J.; Kim, S.; Park, J.W.; Son, E.I.; Lee, T.J.; Kwon, T.K. Helenalin-Induced apoptosis is dependent on production of reactive oxygen species and independent of induction of endoplasmic reticulum stress in renal cell carcinoma. Toxicol. In Vitro, 2013, 27(2), 588-596.
[http://dx.doi.org/10.1016/j.tiv.2012.10.014] [PMID: 23123298]
[18]
Zwicker, P.; Schultze, N.; Niehs, S.; Albrecht, D.; Methling, K.; Wurster, M.; Wachlin, G.; Lalk, M.; Lindequist, U.; Haertel, B. Differential effects of Helenalin, an anti-inflammatory sesquiterpene lactone, on the proteome, metabolome and the oxidative stress response in several immune cell types. Toxicol. In Vitro, 2017, 40, 45-54.
[http://dx.doi.org/10.1016/j.tiv.2016.12.010] [PMID: 27998807]
[19]
Büchele, B.; Zugmaier, W.; Lunov, O.; Syrovets, T.; Merfort, I.; Simmet, T. Surface plasmon resonance analysis of nuclear factor-kappaB protein interactions with the sesquiterpene lactone helenalin. Anal. Biochem., 2010, 401(1), 30-37.
[http://dx.doi.org/10.1016/j.ab.2010.02.020] [PMID: 20175984]
[20]
Tornhamre, S.; Schmidt, T.J.; Näsman-Glaser, B.; Ericsson, I.
Lindgren, J.A. Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. Biochem. Pharmacol., 2001, 62(7), 903-911.
[http://dx.doi.org/10.1016/S0006-2952(01)00729-8] [PMID: 11543725]
[21]
Kim, S.H.; Oh, S.M.; Kim, T.S. Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone. Eur. J. Pharmacol., 2005, 511(2-3), 89-97.
[http://dx.doi.org/10.1016/j.ejphar.2005.02.008] [PMID: 15792776]
[22]
Supornsilchai, V.; Söder, O.; Svechnikov, K. Sesquiterpene lactone helenalin suppresses Leydig and adrenocortical cell steroidogenesis by inhibiting expression of the steroidogenic acute regulatory protein. Reprod. Toxicol., 2006, 22(4), 631-635.
[http://dx.doi.org/10.1016/j.reprotox.2006.04.011] [PMID: 16777379]
[23]
Lin, W.N.; Luo, S.F.; Lee, C.W.; Wang, C.C.; Wang, J.S.; Yang, C.M. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells. Cell. Signal., 2007, 19(6), 1258-1267.
[http://dx.doi.org/10.1016/j.cellsig.2007.01.009] [PMID: 17303384]
[24]
Zhang, Z.; Xu, L.; Cheung, H.Y. The inhibitory effect of helenalin on telomerase activity is attributed to the alkylation of the CYS445 residue: Evidence from QM/MM simulations. J. Mol. Graph. Model., 2014, 51, 97-103.
[http://dx.doi.org/10.1016/j.jmgm.2014.04.012] [PMID: 24863344]
[25]
Eric, N. Clonidine to treat pain locally. EP Patent 2363122A1, 2006.
[26]
Burright, N.E.; Shafer, L.L.; Zanella, J. Systems and methods to treat pain locally.Patent 20100159015, 2010.
[27]
Schmidt, T.J. Helenanolide-type sesquiterpene lactones--III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg. Med. Chem., 1997, 5(4), 645-653.
[http://dx.doi.org/10.1016/S0968-0896(97)00003-5] [PMID: 9158862]
[28]
Heilmann, J.; Wasescha, M.R.; Schmidt, T.J. The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. Bioorg. Med. Chem., 2001, 9(8), 2189-2194.
[http://dx.doi.org/10.1016/S0968-0896(01)00131-6] [PMID: 11504656]
[29]
Woerdenbag, H.J.; Merfort, I.; Schmidt, T.J.; Passreiter, C.M.; Willuhn, G.; Van Uden, W.; Pras, N.; Konings, A.W. Decreased helenalin-induced cytotoxicity by flavonoids from Arnica as studied in a human lung carcinoma cell line. Phytomedicine, 1995, 2(2), 127-132.
[http://dx.doi.org/10.1016/S0944-7113(11)80057-7] [PMID: 23196154]
[30]
Williams, W.L., Jr; Hall, I.H.; Grippo, A.A.; Oswald, C.B.; Lee, K.H.; Holbrook, D.J.; Chaney, S.G. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo. J. Pharm. Sci., 1988, 77(2), 178-184.
[http://dx.doi.org/10.1002/jps.2600770217] [PMID: 2896234]
[31]
Hsieh, H.L.; Wang, H.H.; Wu, C.Y.; Jou, M.J.; Yen, M.H.; Parker, P.; Yang, C.M. BK-induced COX-2 expression via PKC-δ-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell. Signal., 2007, 19(2), 330-340.
[http://dx.doi.org/10.1016/j.cellsig.2006.07.006] [PMID: 16935468]
[32]
Wang, H.J.; Cao, J.P.; Yu, J.K.; Zhang, L.C.; Jiang, Z.J.; Gao, D.S. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway. Eur. J. Pharmacol., 2008, 595(1-3), 7-12.
[http://dx.doi.org/10.1016/j.ejphar.2008.07.044] [PMID: 18703048]
[33]
Lee, I.T.; Lee, C.W.; Tung, W.H.; Wang, S.W.; Lin, C.C.; Shu, J.C.; Yang, C.M. Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses. Am. J. Pathol., 2010, 176(4), 1671-1684.
[http://dx.doi.org/10.2353/ajpath.2010.090714] [PMID: 20167866]
[34]
Luo, S.F.; Lin, W.N.; Yang, C.M.; Lee, C.W.; Liao, C.H.; Leu, Y.L.; Hsiao, L.D. Induction of cytosolic phospholipase A2 by lipopolysaccharide in canine tracheal smooth muscle cells: Involvement of MAPKs and NF-kappaB pathways. Cell. Signal., 2006, 18(8), 1201-1211.
[http://dx.doi.org/10.1016/j.cellsig.2005.09.011] [PMID: 16278065]
[35]
Luo, S.F.; Lin, C.C.; Chen, H.C.; Lin, W.N.; Lee, I.T.; Lee, C.W.; Hsiao, L.D.; Yang, C.M. Involvement of MAPKs, NF-kappaB and p300 co-activator in IL-1β-induced cytosolic phospholipase A2 expression in canine tracheal smooth muscle cells. Toxicol. Appl. Pharmacol., 2008, 232(3), 396-407.
[http://dx.doi.org/10.1016/j.taap.2008.07.019] [PMID: 18708082]
[36]
Jakobs, A.; Steinmann, S.; Henrich, S.M.; Schmidt, T.J.; Klempnauer, K.H. Helenalin acetate, a natural sesquiterpene lactone with anti-inflammatory and anti-cancer activity, disrupts the cooperation of CCAAT box/enhancer-binding protein β (C/EBPβ) and co-activator p300. J. Biol. Chem., 2016, 291(50), 26098-26108.
[http://dx.doi.org/10.1074/jbc.M116.748129] [PMID: 27803164]
[37]
Shin, H.J.; Youn, H.S.; Son, B.S.; Youn, H.S. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by helenalin. Life Sci., 2013, 93(22), 847-854.
[http://dx.doi.org/10.1016/j.lfs.2013.09.004] [PMID: 24044884]
[38]
Hoffmann, R.; von Schwarzenberg, K.; López-Antón, N.; Rudy, A.; Wanner, G.; Dirsch, V.M.; Vollmar, A.M. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation. Biochem. Pharmacol., 2011, 82(5), 453-463.
[http://dx.doi.org/10.1016/j.bcp.2011.05.029] [PMID: 21669190]
[39]
Committee for veterinary medicinal products-Arnica montana. European agency for the evaluation of medicinal products, veterinary medicinal evaluation unit 1999. Available at https://www.ema.europa.eu/en/committees/committee-medicinal-products-veterinary-use-cvmp
[40]
Ghasemali, S.; Nejati-Koshki, K.; Tafsiri, E.; Rahmati-Yamchi, M.; Akbarzadeh, A.; Alizadeh, E.; Abbasi, M.; Barkhordari, A.; Tozihi, M.; Kordi, S.; Zarghami, N. Inhibitory effects of β-cyclodextrin-helenalin complexes on H-TERT gene expression in the T47D breast cancer cell line - results of real time quantitative PCR. Asian Pac. J. Cancer Prev., 2013, 14(11), 6949-6953.
[http://dx.doi.org/10.7314/APJCP.2013.14.11.6949] [PMID: 24377631]
[41]
Chandran, B.; Goel, A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res., 2012, 26(11), 1719-1725.
[42]
Mendes, A.M.; Vilela, D.C.H.; Jung, M.T.; Okuyama, S.S.K.; Machado, M.; Lima, A.; de Azevedo, L.R.; Grégio, M.T. Therapeutic effect of arnica ointment on cicatrization process of aphthas and lesions in human oral mucosa. Pharmacologyonline, 2008, 3, 273-280.
[43]
Kriplani, P.; Guarve, K.; Baghael, U.S. Arnica montana L. - a plant of healing: Review J. Pharm. Pharmacol., 2017, 69(8), 925-945.
[http://dx.doi.org/10.1111/jphp.12724] [PMID: 28401567]
[44]
Widrig, R.; Suter, A.; Saller, R.; Melzer, J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study. Rheumatol. Int., 2007, 27(6), 585-591.
[http://dx.doi.org/10.1007/s00296-007-0304-y] [PMID: 17318618]
[45]
Itoigawa, M.; Takeya, K.; Furukawa, H.; Ito, K. Mode of cardiotonic action of helenalin, a sesquiterpene lactone, on guinea pig ventricular myocardium. J. Cardiovasc. Pharmacol., 1987, 9(2), 193-201.
[http://dx.doi.org/10.1097/00005344-198702000-00011] [PMID: 2435998]
[46]
Wang, J.; Jiang, S.; Kwong, J.M.; Sanchez, R.N.; Sadun, A.A.; Lam, T.T. Nuclear factor-kappaB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats. Brain Res., 2006, 1081(1), 211-218.
[http://dx.doi.org/10.1016/j.brainres.2006.01.077] [PMID: 16530172]
[47]
Schröder, H.; Lösche, W.; Strobach, H.; Leven, W.; Willuhn, G.; Till, U.; Schrör, K. Helenalin and 11 α, 13-dihydrohelenalin, two constituents from Arnica montana L., inhibit human platelet function via thiol-dependent pathways. Thromb. Res., 1990, 57(6), 839-845.
[http://dx.doi.org/10.1016/0049-3848(90)90151-2] [PMID: 2116680]
[48]
Lee, K.H.; Haruna, M.; Huang, H.C.; Wu, B.S.; Hall, I.H. Antitumor agents XXIII: Helenalin, and antitumor principle from Anaphalis morrisonicola HAY. J. Pharm. Sci., 1977, 66(8), 1194-1195.
[http://dx.doi.org/10.1002/jps.2600660836] [PMID: 561183]
[49]
Kordi, S.; Zarghami, N.; Akbarzadeh, A.; Rahmati, Y.M.; Ghasemali, S.; Barkhordari, A.; Tozihi, M. A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR. Artif. Cells Nanomed. Biotechnol., 2016, 44(2), 695-703.
[http://dx.doi.org/10.3109/21691401.2014.981270] [PMID: 25435410]
[50]
Lin, C.C.; Tseng, H.W.; Hsieh, H.L.; Lee, C.W.; Wu, C.Y.; Cheng, C.Y.; Yang, C.M. Tumor necrosis factor-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Toxicol. Appl. Pharmacol., 2008, 229(3), 386-398.
[http://dx.doi.org/10.1016/j.taap.2008.01.032] [PMID: 18336852]
[51]
Lim, C.B.; Fu, P.Y.; Ky, N.; Zhu, H.S.; Feng, X.; Li, J.; Srinivasan, K.G.; Hamza, M.S.; Zhao, Y. NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death. BMC Complement. Altern. Med., 2012, 12, 93.
[http://dx.doi.org/10.1186/1472-6882-12-93] [PMID: 22784363]
[52]
Widen, J.C.; Kempema, A.M.; Villalta, P.W.; Harki, D.A. Targeting NF-κB p65 with a helenalin inspired bis-electrophile. ACS Chem. Biol., 2017, 12(1), 102-113.
[http://dx.doi.org/10.1021/acschembio.6b00751] [PMID: 28103680]
[53]
Gertsch, J.; Sticher, O.; Schmidt, T.; Heilmann, J. Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: Anti-inflammatory and cytotoxic effects. Biochem. Pharmacol., 2003, 66(11), 2141-2153.
[http://dx.doi.org/10.1016/j.bcp.2003.08.006] [PMID: 14609739]
[54]
Ren, Y.; Yu, J.; Kinghorn, A.D. Development of anticancer agents from plant-derived sesquiterpene lactones. Curr. Med. Chem., 2016, 23(23), 2397-2420.
[http://dx.doi.org/10.2174/0929867323666160510123255] [PMID: 27160533]
[55]
Chaney, S.G.; Williams, W.L., Jr; Willingham, W., III; Considine, R.T.; Hall, I.H.; Lee, K.H. Inhibition of protein synthesis initiation factors by naturally occurring sulfhydryl reactive reagents. Curr. Top. Cell. Regul., 1984, 24, 251-260.
[http://dx.doi.org/10.1016/B978-0-12-152824-9.50030-7] [PMID: 6094109]
[56]
Lee, K.H.; Anuforo, D.C.; Huang, E.S.; Piantadosi, C. Antitumor agents. I. Augustibalin, a new cytotoxic sesquiterpene lactone from Balduina angustifolia (Pursh.). Robins. J. Pharm. Sci., 1972, 61(4), 626-628.
[http://dx.doi.org/10.1002/jps.2600610431] [PMID: 4335374]
[57]
Hall, I.H.; Lee, K.H.; Okano, M.; Sims, D.; Ibuka, T.; Liou, Y.F.; Imakura, Y. Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells. J. Pharm. Sci., 1981, 70(10), 1147-1150.
[http://dx.doi.org/10.1002/jps.2600701014] [PMID: 7299649]
[58]
Tung, W.H.; Sun, C.C.; Hsieh, H.L.; Wang, S.W.; Horng, J.T.; Yang, C.M. EV71 induces VCAM-1 expression via PDGF receptor, PI3-K/Akt, p38 MAPK, JNK and NF-kappaB in vascular smooth muscle cells. Cell. Signal., 2007, 19(10), 2127-2137.
[http://dx.doi.org/10.1016/j.cellsig.2007.06.009] [PMID: 17669626]
[59]
Boulanger, D.; Brouillette, E.; Jaspar, F.; Malouin, F.; Mainil, J.; Bureau, F.; Lekeux, P. Helenalin reduces Staphylococcus aureus infection in vitro and in vivo. Vet. Microbiol., 2007, 119(2-4), 330-338.
[http://dx.doi.org/10.1016/j.vetmic.2006.08.020] [PMID: 17010538]
[60]
Chen, W.N.; Liu, L.L.; Jiao, B.Y.; Lin, W.S.; Lin, X.J.; Lin, X. Hepatitis B virus X protein increases the IL-1β-induced NF-κB activation via interaction with Evolutionarily Conserved Signaling Intermediate in Toll pathways (ECSIT). Virus Res., 2015, 195(2), 236-245.
[http://dx.doi.org/10.1016/j.virusres.2014.10.025] [PMID: 25449573]
[61]
Schmidt, T.J.; Brun, R.; Willuhn, G.; Khalid, S.A. Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. Planta Med., 2002, 68(8), 750-751.
[http://dx.doi.org/10.1055/s-2002-33799] [PMID: 12221603]
[62]
Witzel, D.A.; Ivie, W.; Dollahite, J.W. Mammalian toxicity of helenalin, the toxic principle of Helenium microcephalum CD (smallhead sneezeweed). Am. J. Vet. Res., 1976, 37(7), 859-861.
[PMID: 937811]
[63]
Hall, I.H.; Lee, K.H.; Starnes, C.O.; Muraoka, O.; Sumida, Y.; Waddell, T.G. Antihyperlipidemic activity of sesquiterpene lactones and related compounds. J. Pharm. Sci., 1980, 69(6), 694-697.
[http://dx.doi.org/10.1002/jps.2600690622] [PMID: 7205585]
[64]
Rumack, B.H. POISINDEX(R) Information System Micromedex, Inc; CCIS, 2017, Vol. 172, edition expires May, 2017.
[65]
Merrill, J.C.; Kim, H.L.; Safe, S.; Murray, C.A.; Hayes, M.A. Role of glutathione in the toxicity of the sesquiterpene lactones hymenoxon and helenalin. J. Toxicol. Environ. Health, 1988, 23(2), 159-169.
[http://dx.doi.org/10.1080/15287398809531103] [PMID: 3343693]
[66]
Brito, N.; Knipschild, P.; Doreste-Alonso, J. Systematic review on the efficacy of topical Arnica montana for the treatment of pain, swelling and bruises. J. Musculoskeletal Pain, 2014, 22(2), 216-223.
[http://dx.doi.org/10.3109/10582452.2014.883012]

Rights & Permissions Print Cite
Article Metrics
18
3
© 2024 Bentham Science Publishers | Privacy Policy